Home Analyst Ratings Baird upgrades Henry Schein Inc. to an Outperform rating with a...

Baird upgrades Henry Schein Inc. [HSIC] to an Outperform rating with a $79 price target

Baird took its Henry Schein Inc. [NASDAQ:HSIC]‎‎ rating to the equivalent of Outperform from ‎Neutral, ‎and the price target to $79 from $70, ‎in a research note dated January 4, 2021. That figure ‎represents around a 18.16% premium ‎from ‎where the company’s shares closed on Thursday. ‎Other ‎analysts also revised their coverage, with Barrington Research’s analysts upgrading the shares ‎from “a ‎Mkt perform” rating to “an Outperform” rating in a research note to investors issued in ‎early ‎November. Meanwhile, Barrington Research had lowered its rating on HSIC to “Mkt perform” ‎from the ‎earlier “an Outperform”, in a research note produced for clients May 06, 2020. In addition, ‎there was ‎an upgrade from Goldman on April 07, 2020. The rater changed HSIC from “a Neutral” to “a ‎Buy”.

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. ‎‎

Is Henry Schein Inc. [NASDAQ:HSIC] a ‎Good Buy Right Now?

It should be noted that HSIC ‎technical indicators for short, intermediate as ‎well as long term progress have placed an overall ‎average of 80% as Buy. The average signal changed ‎from 80% Buy in the last week and compares with ‎‎72% Buy in the past month. Data from Henry Schein ‎Inc.’s Trend Spotter indicated that the signals were ‎Bullish. The stock current average is 0.74 million ‎shares in the past 20 days and the short term average ‎signal indicates a 50% Buy. In the last 50 days, ‎the average trading volume was 0.98 million shares while ‎the medium term average advocated for ‎‎100% Buy. The average long-term signal stands at 100% Buy ‎and the 100-day average volume stands at ‎‎0.98 million shares.‎‎

HSIC Price Performance

On Wall Street, Henry Schein Inc. ‎‎[NASDAQ:HSIC] finished ‎Thursday’s session up 1.55% at $66.86. The stock went up to $66.94 at the ‎same session while its ‎lowest single day price was $65.425. In the last five days, it saw a rise of about ‎‎0.63%, Henry Schein Inc. ‎shares gained by almost 0.21% since the beginning of the year. However, the ‎share price has dropped ‎to as low as -9.64% below its one year high. On 02/19/20, the company shares ‎recorded $73.99, the ‎highest single-day price it has got to in the last 52-weeks and a 52-week low was ‎seen on 03/23/20, the ‎same year at $41.85. The company’s shares have declined by -0.39% in the past ‎year. The 50-day SMA ‎achieved is $65.69 while the 200-day SMA is $60.98. Volume dropped to 0.4 ‎million from 0.49 million in ‎the previous session.‎‎

Henry Schein Inc. [HSIC] Valuation ‎Measures

Notably, Henry Schein Inc. [HSIC] stock can be ‎classified as a good candidate in the ‎listing of underestimated low-priced Medical Distribution ‎companies to purchase soonest possible ‎with the prevailing 12-month PE ratio of 16.44. The measure ‎means the stock is exchanging at a ‎discount as compared to the 17.60x trailing earnings of the industry. ‎It can be helpful for investors to ‎consider historical price-sales ratio, more specifically, a 0.98 PS value ‎ratio is reported for the last one ‎year of reported earnings. That is higher than the industry average of ‎‎0.49 which means HSIC serve an ‎attractive investment opportunity compared to its competitors.‎‎

HSIC Stock Support And ‎Resistance Levels

On the 24-hour scale, the immediate backing is ‎perceived around 65.88 level, ‎and in case of violation of this particular level, it will cause more drop to ‎‎64.89 level. On the upper level, ‎‎67.92 is still the key resistance. The stock may increase to the ‎subsequent resistance at 67.39. The ‎Relative Strength Index (RSI) pinned on the 14-day chart is 51.15, ‎implying a neutral technical stance ‎while the MACD stands at -1.16, meaning price will decrease in the ‎next trading period. Percent R ‎indicator moved to 72.40%, implying bearish price movement. ‎Stochastic %K at 16.11% suggest selling ‎the stock.‎‎

What is the short interest in Henry Schein Inc.?

Short interest in the Henry Schein ‎Inc. stock ‎has surged, increasing by 0.48 million shares to total 5.26 million shares on Dec 14, 2020. The ‎interest ‎had seen shares on Nov 12, 2020 stand at 5.74 million, data from Yahoo Finance shows. The ‎decrease ‎of -9.13% suggests the stock saw some decreased bullish sentiment. The stock’s days to ‎cover (short ‎ratio) moved to while the shorted shares account for just 4.80% of the overall float for the ‎stock.‎‎

Henry Schein Inc.’s Biggest Shareholders: Who Owns Henry Schein Inc. [HSIC]?

Filings ‎by The ‎Vanguard Group, Inc. showed that the firm now holds a total of 15,411,479 shares or roughly ‎‎10.79% of ‎the outstanding HSIC shares. This means their shares have reduced by -1,043,154 from the ‎‎15,411,479 ‎the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, ‎Generation ‎Investment Management updated stake is worth $863,870,699. Details in the latest 13F ‎filings reveal ‎that Longview Partners LLP disposed off their -3.39% stake valued at $862,029,568 while ‎BlackRock ‎Fund Advisors added theirs at $526,917,618. During the last quarter, Longview Partners LLP ‎liquidated -‎‎470,882 of its shares in Henry Schein Inc. while BlackRock Fund Advisors bought 334,320 ‎shares. The ‎SSgA Funds Management, Inc.’s holdings currently number 7,479,220 shares at ‎‎$500060649.2. ‎According to the firm’s last 13F report, Brown Brothers Harriman & Co. shares in the ‎company at filing ‎stood at 4,891,381 shares, roughly $314,564,712.‎‎

HSIC Earnings Forecast For The ‎Current Quarter

Henry Schein Inc. [HSIC] is expected to ‎report strong earnings results for the ‎quarter ending on Dec 2020. Consensus estimates give the ‎company expected revenues of $2.87B and ‎an earnings per share of $0.99 for Dec 2020. Looking ‎further ahead, the company is expected to report ‎revenue of $2.62B at an EPS of $0.86 for Mar 2021. ‎The estimates represent upside of 11.20% and ‎‎27.93% in the company’s revenue and earnings per ‎share, respectively, on a year-on-year basis.‎‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

HSIC Earnings Estimates For The ‎Current ‎Year

For the financial year, Henry Schein Inc. [NASDAQ:HSIC] is expected to bring in ‎revenue of ‎‎$9.83B. The returns are nearly $-160.0 million lower than the company’s actual revenue ‎recorded in the ‎fiscal year 2019. In terms of EPS for the 2020, estimate put it at 2.96, lower than that of ‎FY19 by -$0.55. ‎Estimates put this year’s earnings growth at -15.70%, 28.00% for the next, and at an ‎annual 5.43% over ‎the next 5-year period. As for sales, forecasts are for a decrease of -1.50% in the ‎current fiscal year and ‎a further 11.20% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Prompted INVO Biosciences’ After-Hours Rally?

A spike in INVO Bioscience, Inc's (NASDAQ: INVO) stock price after-hours drove its price up 83.28% on Monday. In regular sessions, through the end...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

Tron (TRX) Working Hard on DeFi Development; Where is TRX Heading?

Tron 2021 Global DeFi Hackathon developer contest is one of its $120 million TRON DeFi Entrepreneurial Alliance Support Program.  TRON (TRX) is making sure that it...

Mark Cuban backs Dogecoin (DOGE) and says Dallas Mavericks are the largest merchant of Meme Coin worldwide

After Elon Musk, Cuban comes out in favor of the meme coin. Dogecoin (DOGE) is one of the most anticipated cryptocurrencies of the future. Back...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.